Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,874 | 7 | 74.0% |
| Travel and Lodging | $11,004 | 2 | 25.5% |
| Food and Beverage | $195.99 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $21,269 | 5 | $0 (2019) |
| Roche Products Limited | $18,408 | 4 | $0 (2017) |
| Genentech, Inc. | $3,283 | 1 | $0 (2019) |
| Celgene Corporation | $114.75 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $7,171 | 2 | F. Hoffmann-La Roche AG ($3,889) |
| 2018 | $6,523 | 2 | F. Hoffmann-La Roche AG ($6,523) |
| 2017 | $29,380 | 7 | Roche Products Limited ($18,408) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,282.50 | General |
| Category: None | ||||||
| 04/30/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,888.50 | General |
| Category: None | ||||||
| 10/01/2018 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,450.83 | General |
| Category: None | ||||||
| 03/05/2018 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,071.92 | General |
| Category: None | ||||||
| 10/26/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $114.75 | General |
| Category: Hematology / Oncology | ||||||
| 09/19/2017 | Roche Products Limited | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $10,439.31 | General |
| Category: None | ||||||
| 09/19/2017 | Roche Products Limited | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $7,322.50 | General |
| Category: None | ||||||
| 09/19/2017 | Roche Products Limited | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $564.59 | General |
| Category: None | ||||||
| 09/19/2017 | Roche Products Limited | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $81.24 | General |
| Category: None | ||||||
| 04/12/2017 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,661.25 | General |
| Category: None | ||||||
| 01/02/2017 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $7,196.25 | General |
| Category: None | ||||||
About Dr. Isabel Cunningham, M.D
Dr. Isabel Cunningham, M.D is a Hematology healthcare provider based in Jamaica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235346693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Isabel Cunningham, M.D has received a total of $43,074 in payments from pharmaceutical and medical device companies, with $7,171 received in 2019. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($31,874).
Practice Information
- Specialty Hematology
- Location Jamaica, NY
- Active Since 05/16/2007
- Last Updated 01/06/2012
- Taxonomy Code 207RH0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235346693
Products in Payments
- Non-Covered Product (Drug) $42,959
- Revlimid (Drug) $114.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.